MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025)
MeiraGTx Holdings posted quarterly Enterprise Value of -$65.9 million for Q4 2025, up 36.4% year-on-year from -$48.3 million in Q4 2024, and down 344.25% on a QoQ basis from -$14.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Enterprise Value data on file, last reported at -$65.9 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 36.4% year-over-year to -$65.9 million; the trailing twelve-month figure through Dec 2025 stood at -$65.9 million (up 36.4% YoY), and the FY2025 full-year result was -$65.9 million, up 36.4% from the prior year.
- Enterprise Value for Q4 2025 stood at -$65.9 million, down from -$14.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$14.8 million in Q3 2025 and bottomed at -$199.4 million in Q1 2021.
- The 5-year median for Enterprise Value is -$108.7 million (2022), against an average of -$102.8 million.
- The widest annual swing landed in 2024, when Enterprise Value tumbled 94.14%; it then soared 88.13% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$137.7 million in 2021, then grew by 16.11% to -$115.5 million in 2022, then declined by 13.1% to -$130.6 million in 2023, then grew by 20.66% to -$103.7 million in 2024, then surged by 36.4% to -$65.9 million in 2025.
- The last three Enterprise Value figures came in at -$65.9 million (Q4 2025), -$14.8 million (Q3 2025), and -$32.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | -65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65.93 Mn |
| Sep 30, 2025 | -14.84 Mn |
| Jun 30, 2025 | -32.17 Mn |
| Mar 31, 2025 | -66.52 Mn |
| Dec 31, 2024 | -103.66 Mn |
| Sep 30, 2024 | -125.03 Mn |
| Jun 30, 2024 | -101.03 Mn |
| Mar 31, 2024 | -120.27 Mn |
| Dec 31, 2023 | -130.65 Mn |
| Sep 30, 2023 | -64.40 Mn |
| Jun 30, 2023 | -92.77 Mn |
| Mar 31, 2023 | -68.78 Mn |
| Dec 31, 2022 | -115.52 Mn |
| Sep 30, 2022 | -114.71 Mn |
| Jun 30, 2022 | -72.11 Mn |
| Mar 31, 2022 | -113.78 Mn |
| Dec 31, 2021 | -137.70 Mn |
| Sep 30, 2021 | -143.63 Mn |
| Jun 30, 2021 | -172.56 Mn |
| Mar 31, 2021 | -199.41 Mn |
| Dec 31, 2020 | -209.52 Mn |
| Sep 30, 2020 | -179.59 Mn |
| Jun 30, 2020 | -194.81 Mn |
| Mar 31, 2020 | -210.79 Mn |
| Dec 31, 2019 | -227.23 Mn |
| Sep 30, 2019 | -253.45 Mn |
| Jun 30, 2019 | -204.40 Mn |
| Mar 31, 2019 | -227.40 Mn |
| Dec 31, 2018 | -68.20 Mn |
| Sep 30, 2018 | -88.68 Mn |
| Jun 30, 2018 | -102.18 Mn |
| Mar 31, 2018 | -32.48 Mn |
| Dec 31, 2017 | -8.67 Mn |
| Sep 30, 2017 | -5.42 Mn |
| Jun 30, 2017 | -5.33 Mn |